DSIP (Delta Sleep-Inducing Peptide)

Research Phase
Sleep & Wellness
DSIP (Delta Sleep-Inducing Peptide)

A neuropeptide that promotes deep delta-wave sleep, normalizes circadian rhythms, and reduces stress hormone levels.

Administration

Subcutaneous injection or intranasal

Dosage Range

100-200 mcg before bedtime

Mechanism of Action

DSIP modulates sleep architecture by enhancing delta-wave (slow-wave) sleep phases, reduces cortisol and ACTH levels, and normalizes disrupted circadian rhythms through hypothalamic regulation.

Clinical Benefits

Promotes deep restorative sleep
Reduces cortisol levels
Normalizes circadian rhythm
Reduces chronic pain perception
Supports stress resilience

Clinical Evidence

Clinical studies demonstrate improved sleep quality and reduced sleep latency. Research shows normalization of disrupted sleep patterns in chronic insomnia patients and reduced withdrawal symptoms in substance dependence.

Side Effects

Morning grogginess
Vivid dreams
Mild headache

Contraindications

Severe depression
Sleep apnea (untreated)
Pregnancy

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapy should only be administered under the supervision of a qualified healthcare provider. Always consult your physician before starting any new treatment protocol.